Navigation Links
Study: Cutting emissions pays for itself
Date:8/24/2014

CAMBRIDGE, Mass-- Lower rates of asthma and other health problems are frequently cited as benefits of policies aimed at cutting carbon emissions from sources like power plants and vehicles, because these policies also lead to reductions in other harmful types of air pollution.

But just how large are the health benefits of cleaner air in comparison to the costs of reducing carbon emissions? MIT researchers looked at three policies achieving the same reductions in the U.S., and found that the savings on health care spending and other costs related to illness can be big in some cases, more than 10 times the cost of policy implementation.

"Carbon-reduction policies significantly improve air quality," says Noelle Selin, an assistant professor of engineering systems and atmospheric chemistry at MIT, and co-author of a study published today in Nature Climate Change. "In fact, policies aimed at cutting carbon emissions improve air quality by a similar amount as policies specifically targeting air pollution."

Selin and colleagues compared the health benefits to the economic costs of three climate policies: a clean-energy standard, a transportation policy, and a cap-and-trade program. The three were designed to resemble proposed U.S. climate policies, with the clean-energy standard requiring emissions reductions from power plants similar to those proposed in the Environmental Protection Agency's Clean Power Plan.

Health savings constant across policies

The researchers found that savings from avoided health problems could recoup 26 percent of the cost to implement a transportation policy, but up to to 10.5 times the cost of implementing a cap-and-trade program. The difference depended largely on the costs of the policies, as the savings in the form of avoided medical care and saved sick days remained roughly constant: Policies aimed at specific sources of air pollution, like power plants and
'/>"/>

Contact: Andrew Carleen
acarleen@mit.edu
617-253-1682
Massachusetts Institute of Technology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Study: Worlds primary forests on the brink
2. New study: Ravens rule Idahos artificial roosts
3. Study: arctic mammals can metabolize some pesticides, limits human exposure
4. Study: Marine pest provides advances in maritime anti-fouling and biomedicine
5. Study: Climate change and air pollution will combine to curb food supplies
6. Mouse study: Natural birth may strengthen the immune system
7. USF study: Amphibians can acquire resistance to deadly fungus
8. New study: Ancient Arctic sharks tolerated brackish water 50 million years ago
9. Study: To address climate change, nothing substitutes for reducing CO2 emissions
10. Study: In wild yak society, moms are the real climbers
11. Study: Iron consumption can increase risk for heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... Feb. 3, 2015 Despite a lack ... industries such as consumer electronics, automotive, storage and ... mount technology (SMT) screen printers. Innovations in electronics ... will push the adoption curve up. Meanwhile, sale ... as glue dispensers are indispensable in the production ...
(Date:1/22/2015)... 2015 /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics industry ... new website design. "When we launched FindBiometrics 12 ... Peter O,Neill , founder and CEO of FindBiometrics. "Now it,s ... from the key players on a very broad scale.  We ...
(Date:1/22/2015)... 2015  BellBrook Labs, a leader in high throughput ... of a TR-FRET (time resolved Forster resonance energy ... a high throughput screening assay for glycosyltransferases and ... for sensitive detection of hundreds of human and ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
... University of Illinois have used an innovative approach to ... The research team focused on the expression of behavior-related ... which little genetic data was available when the study ... Express. Like honey bee workers, wasp workers give ...
... Sciences, a Roche company, today reported that researchers from ... FLX system to sequence the entire mitochondrial genomes from ... Sequencing of Mitochondria from Ancient Hair Shafts" appears online ... The study describes a novel way to study the ...
... learn to shut off the portion of their brain that ... them and instead activate a portion of the brain connected ... at the University of Chicago. Because doctors sometimes ... the healing process, they also must develop the ability to ...
Cached Biology News:Wasp genetics study suggests altruism evolved from maternal behavior 2Wasp genetics study suggests altruism evolved from maternal behavior 3454 Sequencing: Science paper describes a novel, highly efficient method of sequencing ancient DNA 2Doctors learn to control their own brains' pain responses to better treat patients 2Doctors learn to control their own brains' pain responses to better treat patients 3
(Date:2/27/2015)... 27, 2015 Bionomics Limited (ASX:BNO, ADR:BMICY) is ... of BNC105 in patients with metastatic renal cancer at ... Florida . The data will be presented by ... Hope Comprehensive Cancer Center in California ... new data identifies Ferritin and IL-8 as two baseline ...
(Date:2/27/2015)... Feb. 27, 2015   PureTech , a science ... commercializing disruptive products and technologies in the healthcare sector, ... former CEO and Member of the Board of Directors ... "It,s has been a pleasure to know Chris ... we will be working together more closely now," said ...
(Date:2/26/2015)...   Synageva BioPharma Corp. (NASDAQ: ... products for rare disorders, today reported 2014 full ... key objectives, and financial guidance.  Synageva,s management team ... p.m. EST to review the financial results and ... today,s call by telephone, please dial (877) 445-4603 ...
(Date:2/26/2015)... On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured a ... Genewiz Inc. in excess of $10 million. The jury ... secrets, and that it improperly hired one or more ... denying motions for judgment notwithstanding the verdict, a new ...
Breaking Biology Technology:New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
... 3 Catalyst,Pharmaceutical Partners, Inc. (Nasdaq: CPRX ... and commercializes prescription,drugs for the treatment of drug ... J. McEnany, Chief Executive,Officer, will be presenting an ... 10th Annual Global Investment Conference on Tuesday, November ...
... - Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) announced ... its U.K. combination REOLYSIN(R) and docetaxel clinical trial,for ... of the Royal Surrey Hospital, U.K., presented the,results ... Cancer,(iSBTC) annual meeting on November 1, 2008. The ...
... AEterna Zentaris Inc.,(NASDAQ: AEZS ; TSX: AEZ), ... oncology, today reported that it has entered the,second ... trial in endometrial,cancer with AEZS-108, a luteinizing hormone-releasing ... enter the second stage of,patient recruitment was taken ...
Cached Biology Technology:Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference 2Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 2Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 3Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 2AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 3AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 4AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108 5
Similar to proteasome (prosome, macropain) 26S subunit, ATPase, 1 Antigen: Recombinant Protein...
RABBIT ANTI AMPHOTERIN...
See product name for description....
5,6 Carboxyfluorescein is conjugated to BSA (bovine serum albumin) protein through amide bonds....
Biology Products: